Mérieux NutriSciences deal expands OTC and supplement testing
The Certified Group acquisition will add 31 North American laboratories and expand testing services for OTC products, dietary supplements, and cosmetics.
The Certified Group acquisition will add 31 North American laboratories and expand testing services for OTC products, dietary supplements, and cosmetics.
TSE 2026 in Boston showed an industry aiming to expand pharmacy’s community role in healthcare amidst reimbursement pressures, technological shifts, and retail changes.
NACDS unveiled the direction of a new strategic framework at Total Store Expo focused on shaping pharmacy’s future and strengthening value for members.
The collaboration could help the company improve shade accuracy, develop more natural, consistent formulas, and enhance inclusivity across its luxury beauty portfolio.
The nonprofit is directly supporting Indonesia’s nationwide vitamin A campaign for the first time after more than a decade of work in the country.
New CVS Caremark research identifies GLP-1 management, biosimilars and digital tools as key opportunities to improve affordability.
Executive order calls for fewer universally recommended childhood vaccines and separate visits for immunizations, including MMR.
The planned combination will streamline operations while creating a roughly $32 billion global health and wellness business.
NRF expects retailers to be well-stocked for the holidays after an early surge in imports shifted the traditional peak shipping season earlier.
As employers reconsider PBM relationships, SHARx warns switching vendors may not address the root incentives behind prescription drug costs.
Half of the women surveyed said they do not always fully understand how their bodies work or what they need to support overall wellness.
The association is calling on CMS to ensure new Medicare Part D regulations prevent PBMs from exploiting loopholes and provide fair reimbursement for independent pharmacies.
A survey of peptide users found skepticism toward traditional healthcare, with most relying on independent research, scientific literature, and online communities for health decisions.
New plan phases in tariffs of 100% in 2028 and 200% in 2029 as manufacturers weigh the cost of shifting production to the U.S.
New offering combines prescription savings with interest-free payments to improve adherence and reduce employer healthcare costs.
The goal is to improve early detection, monitor disease progression, enhance clinical trial enrollment, and advance precision medicine for neurodegenerative diseases.